down arrow

Remedium Life

  • Market Cap: Micro Cap
  • Industry: Trading
  • ISIN: INE549S01036
  • NSEID:
  • BSEID: 539561
INR
2.22
0.04 (1.83%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 6.0 lacs

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationRights Issue: Remedium Lifecare Ltd has announced 61:50 rights issue, ex-date: 15 Apr 25
stock-summaryPrice Point
High/Low

1Day

2.182.22

52 Week

1.7329.43
Valuation
Technical
Day's Volume

CASH

6.0 lacs (29.12%) Volume

Shareholding (Dec 2024)

FII

0.00%

Held by 0 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

1.11%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

  • We advise abundant precaution as this company has substantially increased sales and NP. We are not sure this is sustainable. The promoter's stake is only 1% also does not inspire confidence.
2

With a Operating Losses, the company has a Weak Long Term Fundamental Strength

3

With a fall in Operating Profit of -97.17%, the company declared Very Negative results in Dec 24

4

Stock is technically in a Bearish range

5

Risky - Negative EBITDA

6

Underperformed the market in the last 1 year

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Trading

stock-summary
Market cap

INR 90 Cr (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

22

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

3.84

stock-summary
Return on Equity

-107.93%

stock-summary
Price to Book

1.92

Revenue and Profits (1 Year):
Net Sales:
38 Cr
(Quarterly Results - Dec 2024)
Net Profit:
1 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-73.73%
0%
-73.73%
1 Year
-92.09%
0%
-92.09%
2 Years
-73.04%
0%
-73.04%
3 Years
82.4%
0%
82.4%
4 Years
490.03%
0%
490.03%
5 Years
1037.73%
0%
1037.73%

Remedium Life for the last several years.

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
269.49%
EBIT Growth (5y)
-303.30%
EBIT to Interest (avg)
-11.47
Debt to EBITDA (avg)
3.58
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
22.11
Tax Ratio
63.95%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
6.44%
ROE (avg)
23.78%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
22
Price to Book Value
1.92
EV to EBIT
-7.40
EV to EBITDA
-7.41
EV to Capital Employed
1.19
EV to Sales
0.17
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
11.01%
ROE (Latest)
-107.93%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
Bullish
Bollinger Bands
Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
No Trend
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Siddharth Chimanlal Shah (1.11%)

Highest Public shareholder

None

Individual Investors Holdings

86.1%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'24 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is -97.92% vs 939.31% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is -98.34% vs 2,914.47% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "38.15",
          "val2": "1,834.18",
          "chgp": "-97.92%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-5.48",
          "val2": "54.70",
          "chgp": "-110.02%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.88",
          "val2": "0.03",
          "chgp": "2,833.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.76",
          "val2": "45.82",
          "chgp": "-98.34%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-14.36%",
          "val2": "2.98%",
          "chgp": "-17.34%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is -87.14% vs 209.97% in Sep 2023",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is -73.24% vs 35.44% in Sep 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "102.78",
          "val2": "799.03",
          "chgp": "-87.14%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "4.85",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "2.81",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "3.15",
          "val2": "11.77",
          "chgp": "-73.24%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "4.72%",
          "val2": "0.00%",
          "chgp": "4.72%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -94.65% vs 506.37% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -93.21% vs 464.05% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "140.93",
          "val2": "2,633.21",
          "chgp": "-94.65%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.63",
          "val2": "54.70",
          "chgp": "-101.15%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "3.69",
          "val2": "0.03",
          "chgp": "12,200.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "3.91",
          "val2": "57.59",
          "chgp": "-93.21%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-0.45%",
          "val2": "32.42%",
          "chgp": "-32.87%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 692.74% vs 1.00% in Mar 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 502.76% vs 402.78% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "4,041.71",
          "val2": "509.84",
          "chgp": "692.74%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "33.31",
          "val2": "7.47",
          "chgp": "345.92%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3.87",
          "val2": "-0.08",
          "chgp": "4,937.50%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "32.73",
          "val2": "5.43",
          "chgp": "502.76%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.82%",
          "val2": "1.47%",
          "chgp": "-0.65%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Standalone) - Dec'24 - YoYstock-summary
Dec'24
Dec'23
Change(%)
Net Sales
38.15
1,834.18
-97.92%
Operating Profit (PBDIT) excl Other Income
-5.48
54.70
-110.02%
Interest
0.88
0.03
2,833.33%
Exceptional Items
0.00
0.00
Standalone Net Profit
0.76
45.82
-98.34%
Operating Profit Margin (Excl OI)
-14.36%
2.98%
-17.34%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in quarter ended Dec 2024 is -97.92% vs 939.31% in Dec 2023

Direction Arrows
Standalone Net Profit

YoY Growth in quarter ended Dec 2024 is -98.34% vs 2,914.47% in Dec 2023

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Standalone) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
102.78
799.03
-87.14%
Operating Profit (PBDIT) excl Other Income
4.85
0.00
Interest
2.81
0.00
Exceptional Items
0.00
0.00
Standalone Net Profit
3.15
11.77
-73.24%
Operating Profit Margin (Excl OI)
4.72%
0.00%
4.72%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is -87.14% vs 209.97% in Sep 2023

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2024 is -73.24% vs 35.44% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Standalone) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
140.93
2,633.21
-94.65%
Operating Profit (PBDIT) excl Other Income
-0.63
54.70
-101.15%
Interest
3.69
0.03
12,200.00%
Exceptional Items
0.00
0.00
Standalone Net Profit
3.91
57.59
-93.21%
Operating Profit Margin (Excl OI)
-0.45%
32.42%
-32.87%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is -94.65% vs 506.37% in Dec 2023

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Dec 2024 is -93.21% vs 464.05% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Standalone) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
4,041.71
509.84
692.74%
Operating Profit (PBDIT) excl Other Income
33.31
7.47
345.92%
Interest
3.87
-0.08
4,937.50%
Exceptional Items
0.00
0.00
Standalone Net Profit
32.73
5.43
502.76%
Operating Profit Margin (Excl OI)
0.82%
1.47%
-0.65%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 692.74% vs 1.00% in Mar 2023

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2024 is 502.76% vs 402.78% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Remedium Lifecare Ltd stock-summary
stock-summary
Remedium Lifecare Ltd
Micro Cap
Trading
Remedium Lifecare Limited (Formerly known as "Roxy Exports Limited) was incorporated in February 19, 1988. Consequent to change in the business activities and accordingly, in order to keep the name of the Company in consonance with the new business activities, the Company changed its name from "Roxy Exports Limited" to "Remedium Lifecare Limited" vide a fresh Certificate of Incorporation on November 6, 2020 issued by the Registrar of Companies.
Company Coordinates stock-summary
Company Details
Office No 601 Hyder Park, Saki Vihar Road Andheri East Mumbai Maharashtra : 400072
stock-summary
Tel:
stock-summary
http://www.remlife.com
stock-summary
roxycyclesin@gmail.com
Registrar Details
Beetal Financial & Computer Services (P) Ltd , Beetal House , 99 Mandangir, 3rd Floor, Behind Local Shopping Centre, Near Dada Harsukhdas Mandir, New Delhi
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."